Login

Berardis, Domenico de

Melatonin, Neuroprotective Agents and Antidepressant Therapy

Berardis, Domenico de - Melatonin, Neuroprotective Agents and Antidepressant Therapy, ebook

352,10€

Ebook, PDF with Adobe DRM
ISBN: 9788132228035
DRM Restrictions

PrintingNot allowed
Copy to clipboardNot allowed

Table of contents

1. History of Pineal Gland as Neuroendocrine Organ and the Discovery of Melatonin
Francisco López-Muñoz, Fernando Marín, Cecilio Álamo

2. Bibliometric Study of Scientific Research on Melatonin During the Last 25 Years
Francisco López-Muñoz, Francisco J. Povedano, Cecilio Álamo

3. Neuroimaging of the Pineal Gland: Focus on Primary Insomnia
J. M. Bumb, Ingo S. Nölte

4. Melatonin: Basic and Clinical Aspects
Agata Carpentieri, Vanessa Areco, Gabriela Díaz Barboza, María Angélica Rivoira, Solange Guizzardi, Nori Tolosa Talamoni

5. Melatonin and Melatonin Receptors in Neuroprotection
Omur Gulsum Deniz, Aysın Pınar Turkmen, Mehmet Emin Onger, Berrin Zuhal Altunkaynak, Suleyman Kaplan

6. Melatonin Supplementation in Neurodegenerative Diseases: Current Status
Giovanni Polimeni, Claudio Guarneri, Salvatore Cuzzocrea

7. Therapeutic Potential of Melatonin in Combination with Other Drugs Against Neurodegeneration
Eva Ramos, Paloma Patiño, José Luis Marco-Contelles, Ramón Cacabelos, Alejandro Romero

8. Melatonin, a Neuroprotective Agent: Relevance for Stress-Induced Neuropsychiatric Disorders
Piyarat Govitrapong, Kasima Ekthuwapranee, Nootchanart Ruksee, Parichart Boontem

9. Melatonin, Sleep, Circadian Rhythm, and Mood Disorders
Venkataramanujam Srinivasan, Domenico Berardis, Michele Fornaro, Francisco López-Muñoz, Timo Partonen, Rahimah Zakaria

10. Melatonin Induces Antidepressant-Like Behavior by Promotion of Adult Hippocampal Neurogenesis
Gerardo Bernabé Ramírez-Rodríguez

11. Association Between Melatonin and Neuroimmune Diseases
Murat Terzi, Mehmet Emin Onger, Aysin Pınar Turkmen, Sefa Ersan Kaya, Arife Ahsen Kaplan, Berrin Zuhal Altunkaynak, Suleyman Kaplan

12. Melatonin in Clinical Status of Patients with Fibromyalgia Syndrome
Andrei Pereira Pernambuco, Marina Barros Pinheiro, Débora Ávila Reis

13. Melatonin’s Beneficial Effects in Hepatic Injury
Pınar Atukeren, Hafize Uzun

14. Melatonin as a Novel Therapeutic Agent Against Chemical Warfare Agents
René Pita, Eva Ramos, José Luis Marco-Contelles, Alejandro Romero

15. New Galenic Formulations of Melatonin
Pilar García-García, Francisco López-Muñoz, Cecilio Álamo

16. Melatonergic Drug Ramelteon in Neurotherapeutics
Venkataramanujam Srinivasan, Rahimah Zakaria, Domenico Berardis, Francisco López-Muñoz, Mohd Jamil Yaacob, Zahiruddin Othman, Amnon Brzezinski

17. Melatonergic Antidepressant Agomelatine and Its Efficacy in Depressive Disorders
Venkataramanujam Srinivasan, Domenico Berardis, Michele Fornaro, Francisco Lopez-Muñoz, Rahimah Zakaria, Mohd Jamil Yaacob, Zahiruddin Othman

18. Agomelatine, Melatonin and Depression
Trevor R. Norman

19. Neuropsychological Models of Depression
Stephan Moratti, Alberto Fernández, Rosa Jurado, Gabriel Rubio

20. Chronobiology of Mood Disorders
Felice Iasevoli, Livia Avvisati, Valentina Gilardi, Gianmarco Latte, Emiliano Prinzivalli, Domenico Berardis, Alessandro Valchera, Michele Fornaro, Carmine Tomasetti, Andrea Bartolomeis

21. Bipolar Disorders and Biological Rhythms
Robert Gonzalez

22. Circadian Clock Genes and Mood Disorders
Timo Partonen

23. Understanding the Biologically Adaptive Side of Mood Disorders: A Focus on Affective Temperaments
Xenia Gonda, Gustavo H. Vazquez

24. Sleep Abnormalities as a Diagnostic Tool for Major Depressive Disorder
Alan B. Douglass, Marcus Ward, Timothy Roerhrs, Cynthia L. Arfken, Nash N. Boutrous

25. Depression: Correlations with Thyroid Hormones in Major Depressive Disorder
Dominika Berent

26. History of the Discovery of Antidepressant Drugs
Francisco López-Muñoz, Cecilio Álamo

27. Neurocognitive Deficit in Bipolar Disorders
Dimos Dimelis, Xenia Gonda, Konstantinos N. Fountoulakis

28. Combination Strategies in Treatment-Resistant Depression
Francisco López-Muñoz, Cecilio Álamo, Pilar García-García

29. Antidepressant Drugs in Elderly
Cecilio Álamo, Francisco López-Muñoz, Pilar García-García

30. Antidepressant Efficacy of Escitalopram in Major Depressive Disorder
Eiji Kirino

31. Antidepressant Medications and Suicide Risk: What Was the Impact of FDA Warning?
Gianluca Serafini, Paola Solano, Mario Amore

32. Neurobiology and Pharmacological Prevention of Suicide in Mood Disorders
Xenia Gonda, Zoltan Rihmer, Peter Dome

33. Antidepressant and Anticonvulsant Drugs as Adjuvant Analgesics in Chronic Pain
Manuel Sebastián-Aldeanueva, Francisco López-Muñoz, José Antonio Guerra, Cecilio Álamo

34. Genetic Polymorphisms of Cytochrome P450 and Antidepressants
Ana Isabel Wu-Chou, Yu-Li Liu, Winston W. Shen

35. Pharmacogenomics of Antidepressant Drugs
Ramón Cacabelos, Clara Torrellas, Francisco López-Muñoz

36. Antidepressants Modulate Microglia Beyond the Neurotransmitters Doctrine of Mood Disorders
Masahiro Ohgidani, Takahiro A. Kato, Yoshito Mizoguchi, Hideki Horikawa, Akira Monji, Shigenobu Kanba

37. Brain-Derived Neurotrophic Factor (BDNF): TrkB Signaling in Depression – Biomarker and Novel Therapeutic Target
Kenji Hashimoto

38. Targeting Opioid Receptors for Innovative Antidepressant Therapies: Rediscovering the Opioid Cure
Emmanuel Darcq, Paul Chu-Sin-Chung, Brigitte L. Kieffer, Pierre-Eric Lutz

39. Prolactin and Somatostatin Responses to Antidepressant Therapy
Agata Faron-Górecka, Kinga Szafran-Pilch

40. The Role of Vasopressin in Anxiety and Depression
Julio Cesar Morales-Medina, Shannah K. Witchey, Heather K. Caldwell

41. Ketamine: The Glutamatergic Antidepressant and Its Efficacy
Derek K. Tracy, Caroline Caddy, Sukhwinder S. Shergill

42. Acetylcholinergic Nicotinic Receptors as Pharmacological Targets for Cognitive Enhancement: Emerging Evidence from Psychosis Populations
Derek K. Tracy, Valentina Casetti, Arann R. Rowe, Louise Mercer, Sukhwinder S. Shergill

43. The Glutamate mGluR5 Receptor as a Pharmacological Target to Enhance Cognitive Function: Emerging Evidence from Psychosis Models
Derek K. Tracy, Nicola Smallcombe, Farah Tiwana, Judith Fosbraey, Kyra-Verena Sendt, Sukhwinder S. Shergill

44. Corticotropin-Releasing Factor Receptors as a Potential Target in the Developments of Antidepressant Drugs
Glenn R. Valdez

45. Nitric Oxide Signaling in Depression and Antidepressant Action
Gregers Wegener, Sâmia R. L. Joca

46. The Role of Arrestins in the Neuroprotective Effects of Antidepressant Drugs
Sofia Avissar, Moran Golan, Valeria Feinshtein, Siyona Kolatkar, Doron Fux, Gabriel Schreiber

47. Antidepressant Drugs and Phosphodiesterases
Zhuoyou Chen, Xifei Yang, Ying Xu, Han-Ting Zhang

48. Effects of Methylphenidate and Atomoxetine on Development of the Brain
Berrin Zuhal Altunkaynak, Mehmet Emin Onger, Aysin Pınar Turkmen, Kıymet Kubra Yurt, Gamze Altun, Murat Yuce, Suleyman Kaplan

49. S-Adenosyl-L-Methionine for Major Depressive Disorder
Domenico Berardis, Laura Orsolini, Felice Iasevoli, Carmine Tomasetti, Monica Mazza, Alessandro Valchera, Michele Fornaro, Giampaolo Perna, Monica Piersanti, Marco Nicola, Giovanni Martinotti, Francisco López-Muñoz, Massimo Giannantonio

50. The Role of Antiepileptic Drugs in Bipolar Depression
Juan D. Molina, Manuel Durán, Francisco López-Muñoz, Cecilio Álamo, Francisco Toledo-Romero

51. Melatonin and Other Neuroprotective Agents Target Molecular Mechanisms of Disease in Amyotrophic Lateral Sclerosis
Anastasios Fotinos, Yongjin Zhu, Lilly L. J. Mao, Nazem Atassi, Edward W. Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit E. Cudkowicz, Xin Wang

Keywords: Medicine & Public Health, Neurology, Psychopharmacology, Internal Medicine

Editor
 
 
 
 
Publisher
Springer
Publication year
2016
Language
en
Edition
1
Page amount
25 pages
Category
Medicine, Health Care, Mode
Format
Ebook
eISBN (PDF)
9788132228035
Printed ISBN
978-81-322-2801-1

Similar titles